Lab
Century Clinical Lab, INC.
Century Clinical Lab, INC. was paid $15K by Medicaid between Jan 2018 and Apr 2019, across 28 billing codes. Its largest line is 80307, Drug test(s), presumptive, any number of drug classes; immunoassay — 86% of everything it billed.
33Billing provider infoCENTURY CLINICAL LAB, INC.
SUNRISE, FL 33326
SUNRISE, FL 33326
33aNPI1245469527assigned 07/08/2009
33bProvider typeClinical Medical Laboratory
28Total paid$15K
24GClaims6,814
24DCodes billed28
24AFirst – last monthJan 2018 – Apr 2019
Compared with peers
Next to other Clinical Medical Laboratory providers in Florida
Rank by total paid#147 of 225
Median peer was paid$74K
This provider vs. median0.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 4,229 | $8K | |
| 2019 | 2,585 | $8K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 86% | 1,524 | 1,039 | $13K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 4.6% | 178 | 123 | $693.11 |
| 80053 | Comprehensive metabolic panel | 3.0% | 696 | 528 | $456.62 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.6% | 860 | 622 | $238.67 |
| 84443 | Thyroid stimulating hormone (TSH) | 1.5% | 449 | 329 | $226.98 |
| 80061 | Lipid panel | 1.3% | 577 | 422 | $190.22 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 216 | 174 | $108.40 |
| 82607 | <1% | 58 | 47 | $47.39 | |
| 81001 | <1% | 210 | 164 | $32.67 | |
| 84480 | <1% | 32 | 19 | $18.92 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 89 | 73 | $11.85 |
| 82746 | <1% | 78 | 41 | $10.94 |
16 more codes
| 84550 | <1% | 28 | $5.48 | |
| 84436 | <1% | 86 | $5.10 | |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 0% | 447 | $0.00 |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 0% | 15 | $0.00 |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | 0% | 159 | $0.00 |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 0% | 23 | $0.00 |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 0% | 22 | $0.00 |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | 0% | 39 | $0.00 |
| 84439 | 0% | 15 | $0.00 | |
| 80171 | 0% | 55 | $0.00 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 0% | 29 | $0.00 |
| 36415 | Collection of venous blood by venipuncture | 0% | 741 | $0.00 |
| 84153 | 0% | 43 | $0.00 | |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 0% | 50 | $0.00 |
| 84479 | 0% | 71 | $0.00 | |
| 87503 | 0% | 24 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialVALDES, RUBEN (CEO)